MIRA
INFORM REPORT
|
Report Date : |
15.05.2012 |
IDENTIFICATION DETAILS
|
Name : |
NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD. |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
28.04.2010 |
|
|
|
|
Com. Reg. No.: |
130000000023983 |
|
|
|
|
Legal Form : |
One-Person Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturing and selling preparation and pharmaceutical raw materials. |
|
|
|
|
No. of Employees : |
800 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name and address
NCPC HEBEI HUAMIN PHARMACEUTICAL Co., Ltd.
NO. 11 YANGZI ROAD,
ECONOMIC & TECHNOLOGICAL DEVELOPMENT ZONE, SHIJIAZHUANG, HEBEI PROVINCE,
052165 PR CHINA
TEL: 86 (0)
311-88152807/83096215 FAX: 86 (0)
311-88152805/83096200
EXECUTIVE SUMMARY
INCORPORATION DATE : APR. 28, 2010
REGISTRATION NO. : 130000000023983
REGISTERED LEGAL FORM : ONE-PERSON LIMITED
LIABILITY COMPANY
STAFF STRENGTH :
800
REGISTERED CAPITAL : CNY 316,379,600
BUSINESS LINE :
MANUFACTURING
TURNOVER :
N/A
EQUITIES :
N/A
PAYMENT :
AVERAGE
MARKET CONDITION : AVERAGE
FINANCIAL CONDITION : N/A
OPERATIONAL TREND : FAIRLY steady
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE :
CNY 6.31 = USD 1
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
CNY - China Yuan Ren Min Bi
SC was registered
as a one-person limited liability company at local Administration for Industry
& Commerce (AIC-The official body of issuing and renewing business license)
on Apr. 28, 2010.
Company
Status: One-person Limited
Liability Company Single person LLC refers to a limited
liability company set up by only one natural person or legal person as the
single shareholder of it. The minimum registered capital
of Single person LLC is CNY100,000. The shareholder’s capital contributes,
as set out by the articles of associations should be a lump-sum payment in
full. One natural person can only
invest in and set up one limited liability company, which is not permitted
to invest in and set up a new Single person LLC. As to any one-person limited
liability company, the sole-investor nature of the natural person or legal
person shall be indicated in the registration documents of the company and
shall be indicated in the business license thereof as well. The regulation of Single person
LLC should be set up by the shareholder The regulation of Single person
LLC has no shareholder meeting.
SC’s registered
business scope includes manufacturing granules preparation (cephalosporins),
injection preparation (cephalosporins), tablets preparation (including
cephalosporins), the hard capsules preparation (including cephalosporins),
sterile bulk drugs, bulk drugs; manufacturing semi-synthetic antibiotic
intermediates; import and export of goods and technology (with permit if
needed).
SC is mainly engaged
in manufacturing and selling preparation and pharmaceutical raw materials.
Mr. Wei
Qingjie is the legal representative,
chairman and general manager of SC at present.
SC is known to
have approx. 800 employees at present.
SC
is currently operating at the above stated address, and this address houses its
operating office and factory in the economic & technological development
zone of Shijiazhuang. SC’s accountant refused to release the detailed
information of the area.
SC
also has another operating office located in No. 56 Tiyu North Street,
Shijiazhuang, factory located in No. 98 Hainan Road, Economic &
Technological Development Zone, Shijiazhuang.
SC is not known to host website of its own at present.
No significant events or changes were found during our checks with local
AIC.
MAIN SHAREHOLDER:
Name %
of Shareholding
North China Pharmaceutical Co., Ltd. 100
Legal representative: Wang Sheping
Registration No.: 130000000008365
Registered capital: CNY 1,028,580,000
Stock code: 600812
Website: http://www.ncpc.com/ncpcintro.html
Tel.: 0311-85992039
Fax: 0311-86060942
Address: No. 388 Heping East Road,
Shijiazhuang, Hebei Province
l
Legal representative, chairman and general manager:
Mr. Wei Qingjie born in 1969 with
university education, senior engineer, he is currently responsible for the
daily management of SC.
Working Experience(s):
At present Working
in SC as legal representative, chairman and general manager;
Also working in NCPC Orchid Pharmaceutical Co., Ltd.
as legal representative and chairman, working in North China Pharmaceutical
Co., Ltd. as vice general manager
Directors:
=======
Liu Chunxiao
Wen Tongli
Liu Hao
Li Yanling
Supervisor:
========
Wang Aili
SC is mainly
engaged in manufacturing and selling preparation and pharmaceutical raw
materials.
SC’s products
mainly include: granules preparation (cephalosporins), injection
preparation (cephalosporins), tablets preparation (including cephalosporins), the
hard capsules preparation (including cephalosporins), sterile bulk drugs, etc.
SC sources its materials 95% from domestic
market and 5% from overseas market. SC sells 80% of its products in domestic
market, and 20% of its products to overseas market, mainly to Southeast Asia.
The buying terms of SC include Check, T/T, L/C, and Credit of 30-60
days. The payment terms of SC include Check, T/T, L/C, and Credit of 30-60
days.
Note:
SC declined to release its major clients and suppliers.
NCPC Orchid Pharmaceutical Co., Ltd.
Overall payment appraisal:
( ) Excellent (
) Good (X) Average (
) Fair ( ) Poor
( ) Not yet determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment
experience (through current enquiry with SC's suppliers), our delinquent
payment and our debt collection record concerning SC.
Trade payment experience: SC did not provide
any name of trade/service suppliers and we have no other sources to conduct the
enquiry at present.
Delinquent
payment record: None in our database.
Debt collection record: No overdue amount owed by SC was placed to us for
collection within the last 6 years.
Bank of
Communications Hebei Branch
Add: No. 22
Ziqiang Road, Shijiazhuang, Hebei Province
Tel:
0311-87017597
AC#：131080060146300002426
Relationship:
Normal.
SC’s financial
reports were not found during our checks with the local Administration for
Industry and Commerce.
SC’s management
declined to release any financial information.
SC is medium-sized in its industry with 2 years development history. In
view of its favorable background, credit up to moderate amount may be
considered.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.71 |
|
|
1 |
Rs.86.34 |
|
Euro |
1 |
Rs.69.22 |
INFORMATION DETAILS
|
Report Prepared
by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.